or Try an Advanced Search...

    Technical Analysis for FHTX - Foghorn Therapeutics Inc.

    Grade Last Price % Change Price Change
    D 5.64 -6.16% -0.37
    FHTX closed down 6.16 percent on Friday, May 24, 2024, on 2.14 times normal volume. It ran into resistance at its 50 day moving average.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical FHTX trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    Fell Below 20 DMA Bearish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Bearish Engulfing Bearish -6.16%
    Fell Below 50 DMA Bearish -6.16%
    Bollinger Band Squeeze Range Contraction -6.16%
    BB Squeeze + Upper Band Touch Range Contraction -6.16%
    Outside Day Range Expansion -6.16%
    Upper Bollinger Band Touch Strength -6.16%
    50 DMA Support Bullish -9.32%
    Older End-of-Day Signals for FHTX ...

       Recent Intraday Alerts

    Alert Time
    200 DMA Support 4 days ago
    Fell Below 200 DMA 4 days ago
    Down 5% 4 days ago
    60 Minute Opening Range Breakdown 4 days ago
    50 DMA Resistance 4 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    FHTX Chart by TradingView
    Basic chart:

    Profile

    Foghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control™ platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The company is developing multiple product candidates in oncology and expects to file an IND for its first program later this year.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Biology Medication

    Is FHTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 23 Foghorn Therapeutics raises ~$110 Million through direct offering
    May 22 Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance Pipeline
    May 20 Foghorn prices $110M mixed-shelf registered direct offering
    May 20 Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded Warrants
    May 9 Foghorn Therapeutics Inc. (NASDAQ:FHTX) Just Reported, And Analysts Assigned A US$11.67 Price Target
    May 7 Foghorn Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
    May 6 Foghorn Therapeutics Q1 2024 Earnings: Misses Analyst Revenue Projections Amidst Strategic ...
    May 6 Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates
    May 6 Foghorn Therapeutics GAAP EPS of -$0.59, revenue of $5.1M
    May 6 Foghorn Therapeutics Provides First Quarter 2024 Financial and Corporate Update
    See more FHTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.96
    52 Week Low 2.7
    Average Volume 81,275
    200-Day Moving Average 5.59
    50-Day Moving Average 6.13
    20-Day Moving Average 5.81
    10-Day Moving Average 5.80
    Average True Range 0.54
    RSI (14) 46.24
    ADX 9.09
    +DI 18.29
    -DI 20.61
    Chandelier Exit (Long, 3 ATRs) 4.89
    Chandelier Exit (Short, 3 ATRs) 6.43
    Upper Bollinger Bands 6.30
    Lower Bollinger Band 5.31
    Percent B (%b) 0.33
    BandWidth 17.12
    MACD Line -0.03
    MACD Signal Line -0.08
    MACD Histogram 0.0492
    Fundamentals Value
    Market Cap 238.1 Million
    Num Shares 42.2 Million
    EPS -2.46
    Price-to-Earnings (P/E) Ratio -2.29
    Price-to-Sales 8.40
    Price-to-Book 10.71
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.45
    Resistance 3 (R3) 6.53 6.33 6.31
    Resistance 2 (R2) 6.33 6.13 6.29 6.27
    Resistance 1 (R1) 5.99 6.00 5.89 5.91 6.22
    Pivot Point 5.79 5.79 5.75 5.76 5.79
    Support 1 (S1) 5.45 5.59 5.35 5.37 5.06
    Support 2 (S2) 5.25 5.46 5.22 5.01
    Support 3 (S3) 4.91 5.25 4.97
    Support 4 (S4) 4.83